The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results from a phase 1 trial of M7824 (MSB0011359C), a bifunctional fusion protein targeting PD-L1 and TGF-β, in advanced solid tumors.
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Celgene (Inst); EMD Serono (Inst)
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology
 
Christopher Ryan Heery
Employment - Bavarian Nordic
Leadership - Bavarian Nordic
Stock and Other Ownership Interests - Bavarian Nordic
Honoraria - MPM Capital
Consulting or Advisory Role - MPM Capital
Travel, Accommodations, Expenses - Bavarian Nordic; MPM Capital
 
Jeffrey Schlom
No Relationships to Disclose
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)
 
Liang Cao
No Relationships to Disclose
 
Elizabeth Lamping
No Relationships to Disclose
 
Jennifer L. Marte
No Relationships to Disclose
 
Lisa M Cordes
No Relationships to Disclose
 
Olaf Christensen
Employment - EMD Serono
 
Christoph Helwig
Employment - Merck KGaA
 
Julius Strauss
No Relationships to Disclose